PFBT
GILD icon

Parkside Financial Bank & Trust’s Gilead Sciences GILD Stock Holding History

Parkside Financial Bank & Trust’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$582K Sell
4,177
-53
-1% -$7.42K 0.04% 238
2025
Q4 		$519K Buy
4,230
+114
+3% +$13.9K 0.04% 261
2025
Q3 		$457K Buy
4,116
+200
+5% +$22.7K 0.04% 269
2025
Q2 		$434K Buy
3,916
+795
+25% +$84.6K 0.05% 266
2025
Q1 		$350K Buy
3,121
+114
+4% +$11.8K 0.04% 274
2024
Q4 		$278K Buy
3,007
+217
+8% +$19.5K 0.04% 310
2024
Q3 		$234K Buy
2,790
+150
+6% +$11.4K 0.03% 339
2024
Q2 		$181K Sell
2,640
-628
-19% -$41.9K 0.03% 367
2024
Q1 		$239K Buy
3,268
+205
+7% +$15.8K 0.04% 317
2023
Q4 		$248K Buy
3,063
+165
+6% +$12.8K 0.05% 271
2023
Q3 		$217K Buy
2,898
+198
+7% +$15.2K 0.05% 248
2023
Q2 		$208K Buy
2,700
+774
+40% +$61.7K 0.05% 253
2023
Q1 		$160K Buy
1,926
+101
+6% +$8.37K 0.04% 274
2022
Q4 		$157K Buy
1,825
+138
+8% +$10.9K 0.05% 269
2022
Q3 		$104K Buy
1,687
+352
+26% +$22.2K 0.03% 326
2022
Q2 		$82K Buy
1,335
+588
+79% +$36.4K 0.03% 389
2022
Q1 		$45K Sell
747
-564
-43% -$36.1K 0.01% 575
2021
Q4 		$95K Sell
1,311
-201
-13% -$13.8K 0.02% 372
2021
Q3 		$106K Buy
1,512
+275
+22% +$19.3K 0.03% 311
2021
Q2 		$85K Buy
1,237
+165
+15% +$11K 0.02% 360
2021
Q1 		$70K Sell
1,072
-745
-41% -$48K 0.02% 386
2020
Q4 		$106K Sell
1,817
-479
-21% -$28.9K 0.03% 304
2020
Q3 		$145K Sell
2,296
-157
-6% -$10.9K 0.05% 224
2020
Q2 		$188K Sell
2,453
-89
-4% -$6.82K 0.06% 207
2020
Q1 		$190K Buy
2,542
+995
+64% +$68.8K 0.07% 179
2019
Q4 		$100K Buy
1,547
+57
+4% +$3.71K 0.03% 298
2019
Q3 		$94K Buy
1,490
+541
+57% +$35.4K 0.03% 288
2019
Q2 		$64K Buy
949
+204
+27% +$13.4K 0.02% 348
2019
Q1 		$48K Buy
745
+73
+11% +$4.85K 0.02% 388
2018
Q4 		$42K Sell
672
-101
-13% -$7.06K 0.02% 393
2018
Q3 		$60K Sell
773
-8
-1% -$604 0.02% 332
2018
Q2 		$55K Buy
781
+72
+10% +$5.08K 0.02% 335
2018
Q1 		$53K Sell
709
-4
-0.6% -$318 0.02% 333
2017
Q4 		$51K Buy
713
+186
+35% +$14.1K 0.02% 357
2017
Q3 		$43K Buy
527
+55
+12% +$4.21K 0.02% 378
2017
Q2 		$34K Buy
472
+211
+81% +$14K 0.01% 414
2017
Q1 		$18K Sell
261
-88
-25% -$6.19K 0.01% 557
2016
Q4 		$25K Sell
349
-49
-12% -$3.64K 0.01% 489
2016
Q3 		$31K Sell
398
-782
-66% -$63.5K 0.01% 472
2016
Q2 		$98K Buy
1,180
+8
+0.7% +$710 0.05% 222
2016
Q1 		$108K Sell
1,172
-175
-13% -$15.8K 0.05% 211
2015
Q4 		$136K Sell
1,347
-76
-5% -$7.91K 0.07% 179
2015
Q3 		$140K Sell
1,423
-1,624
-53% -$180K 0.08% 165
2015
Q2 		$357K Buy
3,047
+31
+1% +$3.39K 0.19% 104
2015
Q1 		$295K Sell
3,016
-189
-6% -$19.2K 0.16% 130
2014
Q4 		$302K Sell
3,205
-15
-0.5% -$1.55K 0.17% 116
2014
Q3 		$343K Sell
3,220
-266
-8% -$26K 0.21% 106
2014
Q2 		$289K Sell
3,486
-609
-15% -$47.4K 0.17% 124
2014
Q1 		$290K Buy
4,095
+998
+32% +$78.3K 0.18% 117
2013
Q4 		$233K Buy
+3,097
New +$216K 0.16% 128

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Parkside Financial Bank & Trust's GILD Position: Q1 2026 in Review

Parkside Financial Bank & Trust reduced its Gilead Sciences (GILD) stake by 1.3% in Q1 2026, selling an estimated $7.42K and leaving 4,177 shares worth $582K. The position accounts for 0.04% of the portfolio, ranked #238.

Parkside Financial Bank & Trust first reported a position in GILD in Q4 2013 and has held it in 50 quarters since. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Parkside Financial Bank & Trust held 4,177 shares of Gilead Sciences worth $582K as of Q1 2026.
  • Parkside Financial Bank & Trust sold 53 Gilead Sciences shares in Q1 2026, an estimated $7.42K.
  • Gilead Sciences made up 0.04% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #238 holding.
  • Parkside Financial Bank & Trust first reported a position in Gilead Sciences in Q4 2013 and has held it in 50 quarters since.
  • 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.